These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9923191)

  • 1. New NO donors with antithrombotic and vasodilating activities, Part 26. Amidoximes and their prodrugs.
    Rehse K; Brehme F
    Arch Pharm (Weinheim); 1998 Dec; 331(12):375-9. PubMed ID: 9923191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New NO-donors with antithrombotic and vasodilating activities, Part 17. Arylazoamidoximes and 3-arylazo-1,2,4-oxadiazol-5-ones.
    Rehse K; Bade S; Harsdorf A; Clement B
    Arch Pharm (Weinheim); 1997 Dec; 330(12):392-8. PubMed ID: 9474899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New NO donors with antithrombotic and vasodilating activities, Part 27. Azide oximes and 1-hydroxytetrazoles.
    Rehse K; Brehme F
    Arch Pharm (Weinheim); 2000 Jun; 333(6):157-61. PubMed ID: 10909186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New NO-donors with antithrombotic and vasodilating activities, Part 16. 3-Amino-1,2,4-oxadiazol-5-ones as prodrugs for hydroxyguanidines.
    Rehse K; Bade S
    Arch Pharm (Weinheim); 1996 Dec; 329(12):535-40. PubMed ID: 9038421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New NO-donors with antithrombotic and vasodilating activities, Part 19. Pseudonitroles and their dimeric azodioxides.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Feb; 331(2):79-84. PubMed ID: 9525092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO donors with antithrombotic and vasodilating activities, Part 23. Organic azides.
    Satyanarayana K; Rehse K
    Arch Pharm (Weinheim); 1998 Jun; 331(6):207-10. PubMed ID: 9713253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New NO donors with antithrombotic and vasodilating activities, part 25. Hydroxylamine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):365-7. PubMed ID: 9881060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New NO-donors with antithrombotic and vasodilating activities, Part 14. 1,3,4-Triazol-1-oles.
    Rehse K; Piechocki D; Schober M; Scheffler H; Reitner N; Unsöld E
    Arch Pharm (Weinheim); 1996 Nov; 329(11):511-3. PubMed ID: 8997901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives.
    Rehse K; König P
    Arch Pharm (Weinheim); 1995 Feb; 328(2):137-42. PubMed ID: 7726739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO donors with antithrombotic and vasodilating activities, Part 28. N-(1-cyanoalkyl)-N-hydroxyureas.
    Camehn R; Rehse K
    Arch Pharm (Weinheim); 2000 Jan; 333(1):27-31. PubMed ID: 10675986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New NO-donors with antithrombotic and vasodilating activities, V: Oligonitroso sydnone imines.
    Rehse K; Schleifer KJ; Martens A; Kämpfe M
    Arch Pharm (Weinheim); 1994 Jun; 327(6):393-7. PubMed ID: 8048846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylazoamidoximes and related compounds as NO-modulators.
    Schröder A; Kotthaus J; Schade D; Clement B; Rehse K
    Arch Pharm (Weinheim); 2010 Jan; 343(1):9-16. PubMed ID: 19921683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New NO-donors with antithrombotic and vasodilating activities, part 15 nitrolic acids.
    Rehse K; Herpel M; Piechocki D
    Arch Pharm (Weinheim); 1996 Feb; 329(2):83-6. PubMed ID: 8851471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in the chemistry and in the biological applications of amidoximes.
    Fylaktakidou KC; Hadjipavlou-Litina DJ; Litinas KE; Varella EA; Nicolaides DN
    Curr Pharm Des; 2008; 14(10):1001-47. PubMed ID: 18473852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel mono and bis nitric oxide donors with high cytocompatibility and release activity.
    Sahyoun T; Gaucher C; Zhou Y; Ouaini N; Schneider R; Arrault A
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3329-3332. PubMed ID: 30243591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New NO-donors with antithrombotic and vasodilating activities, Part 20. Azodioxides activated by electron acceptors in geminal or vicinal position.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Mar; 331(3):104-10. PubMed ID: 9557136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New NO-donors with antithrombotic and vasodilating activities, Part 21. Pseudonitrosites and other azodioxides with vicinal electron acceptors.
    Rehse K; Herpel M
    Arch Pharm (Weinheim); 1998 Mar; 331(3):111-7. PubMed ID: 9557137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New NO donors with antithrombotic and vasodilating activities, Part 29. N-(1-cyanocyclohexyl)-C-phenylnitrones and glyoxaldinitrones.
    Camehn R; Rehse K
    Arch Pharm (Weinheim); 2000 May; 333(5):130-4. PubMed ID: 10863797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Oct; 331(10):308-12. PubMed ID: 9844577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.